Natural vs Synthetic Psychedelic Medicines
Wednesday, May 11, 2022 2:20 PM to 3:00 PM · 40 min. (Europe/London)
Sainsbury Wing Theatre
Panel Discussion
Data & AnalysisDrug DevelopmentLegislation & RegulationResearchTechnology
Information
The majority of traditional psychedelic compounds were extracted from nature, but increasingly psychoactive substances are synthesised and developed in laboratories. What are the advantages of maintaining a natural approach and what are the possible economic, legal and ecological benefits of manufactured medicines?
Audience Q&A
Yes
Legal, Consulting & Business Services
Chris Koddermann
Co-Founder & ChairITPRIPharmaceuticals, Healthcare & Life Sciences
Colin Keating
CEOMindBio TherapeuticsManufacturing & Production
Benjamin Lightburn
CEOFilament Health